Indian Journal of Medical Microbiology IAMM  | About us |  Subscription |  e-Alerts  | Feedback |  Login   
  Print this page Email this page   Small font sizeDefault font sizeIncrease font size
 Home | Ahead of Print | Current Issue | Archives | Search | Instructions  
Users Online: 1411 Official Publication of Indian Association of Medical Microbiologists 
 ~  Similar in PUBMED
 ~  Search Pubmed for
 ~  Search in Google Scholar for
 ~Related articles
 ~  Article in PDF (782 KB)
 ~  Citation Manager
 ~  Access Statistics
 ~  Reader Comments
 ~  Email Alert *
 ~  Add to My List *
* Registration required (free)  

 ~  Abstract
 ~ Introduction
 ~  Materials and Me...
 ~ Results
 ~ Discussion
 ~ Acknowledgement
 ~  References
 ~  Article Figures
 ~  Article Tables

 Article Access Statistics
    PDF Downloaded331    
    Comments [Add]    

Recommend this journal


  Table of Contents  
Year : 2015  |  Volume : 33  |  Issue : 3  |  Page : 378-382

Mumps disease outbreak in Davangere district of Karnataka, India

National Institute of Virology, Bangalore Unit, Bangalore Near NIMHANS, Karnataka - 560 029, India

Date of Submission27-May-2014
Date of Acceptance05-Feb-2015
Date of Web Publication12-Jun-2015

Correspondence Address:
C G Raut
National Institute of Virology, Bangalore Unit, Bangalore Near NIMHANS, Karnataka - 560 029
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/0255-0857.158558

Rights and Permissions

 ~ Abstract 

Background: Mumps is a vaccine-preventable disease that usually occurs as a parotitis, but it can also lead to several life- threatening complications, including pancreatitis, meningitis and encephalitis. Objective: To determine and diagnosis of mumps disease, which is communicable disease usually affects childrens. Although it is seen worldwide, but outbreaks not common in India. Materials and Methods: Thirty one suspected mumps cases, who presented to the unimmunized population of Chikkahallivana village in Davangere district of Karnataka, India in January 2014, with clinical evidence of fever, cervical lymphadenitis and ear pain, manifest with self-limited uni-or bilateral parotitis. A total of 31 cases consisting of 31 blood and 31 throat swabs were tested for diagnosis of mumps disease. Results: Of the 31 suspected cases, laboratory results showed 18 positive for mumps IgM antibodies and 7 cases showed presence of mumps virus RNA by RT-PCR using MV specific nested primers. From 31 cases, 5 were positive with both the methods. Conclusion: We confirmed the cases by serological as well as a sensitive RT-nested PCR-based method and sequencing results for the molecular identification of mumps infection. Sequencing results of the SH gene identified outbreak strain as genotype C, which was consistent with other outbreaks in India.

Keywords: IgM and RT-PCR, mumps disease, unimmunized

How to cite this article:
Raut C G, Sinha D P, Jayaprakash H, Hanumiah H, Manjunatha M J. Mumps disease outbreak in Davangere district of Karnataka, India. Indian J Med Microbiol 2015;33:378-82

How to cite this URL:
Raut C G, Sinha D P, Jayaprakash H, Hanumiah H, Manjunatha M J. Mumps disease outbreak in Davangere district of Karnataka, India. Indian J Med Microbiol [serial online] 2015 [cited 2020 Jun 6];33:378-82. Available from:

 ~ Introduction Top

Mumps disease is caused by Mumps virus (MV), which belongs to the genus Rubulavirus of the subfamily Paramyxovirinae in the family Paramyxoviridae. MV is antigenically monotypic and spreads by respiratory droplets. Mumps is a vaccine-preventable disease that is endemic in most parts of the world. [1]

Mumps disease outbreak occurred in an unvaccinated population of Chikkahallivana village in Davangere district of Karnataka, India in January 2014. Most of the affected unimmunized population belonged to a worker community who opted out of scheduled vaccination. The disease was managed using provincial mumps control guidelines, including programmes for enhanced surveillance and public awareness, in the specific geographic affected region. After the outbreak resolved, we utilized clinical and laboratory data to investigate the period of mumps virus detection, the onset of parotitis and to diagnose laboratory findings with mumps status.

Following natural infection, 10% of infected individuals remain asymptomatic: 40-50% develops a nonspecific respiratory prodrome and ear pain, and the remaining 30-40% manifest with self-limited uni-or bilateral parotitis and cervical lymphadenitis. However, the virus can cause severe complication including meningitis, deafness, pancreatitis and orchitis. [2]

The epidemic curve is presented in [Figure 1], with the beginning of the outbreak in the second week of January, the peak in the last week of January, and the last cases in the first date of February.
Figure 1: Number of cases of mumps reported during the period from 2nd week in January 2014 till the first week of February, 2014

Click here to view

Mumps vaccination has been incorporated into the regular immunization schedule of many countries, usually along with measles and rubella vaccines in a triple formulation. These vaccines have enabled the WHO to establish global strategies for the advanced control of measles and rubella leading to an elimination target in some regions. However, in contrast to rubella and measles, secondary vaccine failure occurs frequently in the case of mumps and circulation of MV within highly vaccinated populations has been frequently reported. [3],[4],[5],[6],[7],[8]

Twelve different genotypes of MV based on genetic variation in the SH gene are currently recognized by the WHO. [2],[9],[10]

MV shows a distinct geographic distribution where more than one genotype may circulate simultaneously in a region. [3] The magnitude and epidemiology of mumps infection in India are poorly understood. There are few literatures available in PubMed related to mumps virus circulation in India. [11],[12],[13],[14]

However, detailed investigations on sporadic cases or outbreak (s) of mumps are necessary to understand the circulation of wild type viruses in the context of the global epidemiology of mumps. [15],[16] This study describes diagnostic tests performed for lab confirmation of mumps cases from a village-Chikkahallivana of Karnataka state, India.

 ~ Materials and Methods Top

Study area

Chikkahallivana is a small village in Davangare district, Karnataka. The district headquarters of Davangare is located at National Highway-4 (Chennai to Mumbai National Highway), Chikkahallivana village is 40 kms away from the district of Davangare and has an estimated population of 364 being rural. The village dwelling setting has two lanes namely, Lane-1 and Lane-2.

Study design

A cross-sectional survey was carried out by three members from the National Institute of Virology, Bangalore Unit with technical support from state Government district medical officer and it was decided that any identified case will be provided necessary treatment at the earliest possible time.


The Chikkahallivana village was covered under this study. The contact was made with the village members to seek their cooperation for the investigation. A total village was surveyed by an investigating team in village who reported having mumps cases. The standard case definition was used for diagnosis of mumps. A disease symptoms criteria was used to clinically identify the mumps cases. A study subject was considered to have mumps if presented with one of the symptoms criteria and any of the minor criteria. [17]

Only the clinical definition of mumps was considered as the index case was already evaluated by experts. [17] The household was a sampling unit and the villagers were extensively covered by house-to-house visits made by the teams. With regard to the uni-or bilateral parotitis or fever cases in the household in the last 3 weeks, if any such case was found, extensive information was collected, for that, study subject enquiries about mumps cases were made from the mothers or responsible persons. Information was collected regarding age, gender, Table-1 history of mumps in the last 3 weeks.

Samples were collected from a total of 31 patients. Distribution of the samples was 31 blood and 31 throat swabs. Throat swabs were collected in virus transport medium. All the samples were carried on cold chain to the laboratory for diagnosis, according to WHO guidelines for specimen collection of mumps virus detection. [18]

Serological test

The blood samples were processed to have the best quality serum and further tested for Mumps IgM antibodies. The test was done with standard positive control using IgM ELISA kit (Calbiotech, CA) as per the protocol. The kit is used for qualitative detection and quantitative determination of specific IgM antibodies to Mumps virus in human serum.

Molecular diagnosis

Total RNA was extracted from 140 μl of throat swab and blood samples using a QIAmp viral RNA kit (Qiagen, Valencia, CA) according to the manufacturer's protocol. RNA was eluted in 50 μl of nuclease free water. For the conventional PCR gel-based platform, a minimum of one standard positive control RNA and one negative control along with samples of target RNA included.

We used diagnostic RNA virus based nested reverse-transcriptase PCR (RT-PCR) to detect mumps virus from clinical samples. [19] A precautions were considered to prevent cross-contamination.

First round of RT-PCR was done using a standard primer pairs (PRV1 forward primer 5'- CGCGTGGTCTACGGGGACACGGA-3' and PRV1 reverse primer 5'- ATGACGCC GATGTACTTCTTCTT-3') to amplify a 600 bp fragment in the SH gene which included the 456 bp amplicon recommended for genotyping. [19] PCR conditions for RT-PCR were reverse transcription step at 42°C for 45 min; followed by 94°C for 2 min for pre-denaturation and denaturation at 94°C for 1 min, annealing at 47°C for 1 min and extension 68°C for 2 min, and an extension at 72°C for 7 min for 35 cycles. Thermocycling was done in a PCR system (Applied Biosystems, Foster City, CA) without an oil overlay.

The second PCR round was performed including 1 μl of undiluted first PCR product as template in a reaction containing 10 mM Tris-HCl (pH 8.3), 50 mM KCl, 200 μM each dNTP, 2.5 mM MgCl 2 , 2.5 units of Taq polymerase (Qiagen, Germany), 10 pmol each of internal control primers PRV2-(5'- GGGACACGGACTCGGTCTTC-3') and PRV2-(5'- CCGGAAGG TCTTCTCGCACTC-3') and 10 pmol each of forward and reverse primers. Nested PCR assays were subjected to an initial cycle of 94°C for 2 min and 30 cycles of 94°C for 1 min, 50°C for 1 min and 72°C for 1 min, followed by final incubation at 72°C for 5 min. After amplification, 10 μl portion of each product was analyzed by agarose gel electrophoresis utilizing 2.0% agarose gel (Sigma Aldrich) and gels were stained with ethidium bromide at 5 μg/ml and visualized by Gel documentation system (Bio-Rad, USA) using the software Quantity One version 4.6.3 to determine the band size. A 1 kb DNA ladder (Invitrogen, Life Technologies) was used as a molecular ladder.

Nucleotide sequencing for genotyping and phylogenetic analysis

The positive mumps viruses of second round PCR products of representative samples were sequenced by dideoxy terminator sequencing method and comparison of the nucleotide sequence was performed using the NCBI BLAST programme with the GenBank database. Mumps SH-gene sequence obtained in this study confirmed with both strands and aligned with WHO reference SH-gene sequence [10] using software ClustalW version 1.83. The viral-DNA sequence was also deposited in Genbank (

 ~ Results Top

Serological investigation of the clinical samples showed 18 children (58%) positive for mumps IgM antibodies, from the total 31 samples subjected to serological analysis. In majority, children below the age of 10 years were found positive for mumps IgM antibodies. Total of six children were found positive between the age of 1-6 years, 11 children between the age of 7-13 years and one positive case of 30 age. Out of total 18 children, five boys and 13 girls were found positive for the mumps IgM antibodies [Table 1]. The results revealed girls were predominantly affected with the mumps disease as compare to boys [Figure 2].
Figure 2: Mumps samples age and sex- wise distribution in Chikkahallivana village

Click here to view
Table 1: Mumps sample distribution and results of IgM and RT-PCR

Click here to view

Molecular assay results

Mumps virus was detected from throat swab, using nested RT-PCR and PCR product size were 448bp with primers targeting the SH genes [Figure 3].
Figure 3: Detection of SH gene by Nested PCR. Lane M: DNA Ladder (1 kb); Lane 1 to 7: Positive Samples; Lane 8: Negative Control; Lane 9: Positive Control

Click here to view

Out of 31 cases, 7 (22%) were confirmed by RT-PCR. All acute phase specimens are positive by RT-PCR. The age group involved was 1-15 yrs. It included two boys and five girls positive with RT-PCR results.

Genotyping results

Sequence information revealed that the sequence from infected mumps virus share 99% homology with Mumps virus strain MuVi/Chennai.IND/45.12 small hydrophobic protein (SH) gene, complete cds having Genbank accession no. KC429765 from Chennai. Sequencing of the SH gene identified outbreak strain as genotype C, was named as MuVi/Davangare. IND and deposited in Genbank (Acc. No. KJ468460, KJ468461) which was consistent with other outbreaks in India. [11],[12],[13]

The phylogeny obtained by analysis of representative strains of all genotypes and our sample sequences allowed quick and easy differentiation of the corresponding genotype [Figure 4]. Phylogenetic tree of mumps virus genotypes based on the 316 nucleotides of the entire small hydrophobic gene: Our isolated virus sequences were matched with WHO reference strains. Neighbour-joining methods of MEGA 5 programme were used. [20] The parameter employed was Kimura 2-parameter model and the robustness of the internal branches was determined by 1000 bootstrap replications. The horizontal length of the bar denotes percentage difference between sequences (see scale at bottom) and the bootstrap numbers (%) are given at each node.
Figure 4: Phylogenetic relationships of the SH sequences of the reference strains and NIV BU sequenced strain for mumps genotyping

Click here to view

The clustering pattern clearly divides two groups, each representing a genotype group included in this study. The bootstra P values ranges from 62-99 for genotype A, F, J and 11-99 for C, E, D, K, M, H, L, I, B, N and G representing of diversity in accession of these mumps strain. The sequence identity of C genotypes with the WHO reference genotype C was ranged from 39 to 99. MuVi/Davangare isolate is close to MuVi/Chennai stain. Furthermore, articles reporting sets of data show temporal changes in the dominant genotype, as well as co-circulation of genotypes in the same or in neighbouring states. According to our findings, these different lineages showed within genotype 'C' that the virus responsible for an outbreaks in South India was similar as earlier reported in India. [11],[12],[13]

 ~ Discussion Top

The use of vaccine in developed countries successfully reduced mumps virus infection, though outbreaks are often reported. Due to absence of effective vaccination programmes, mumps is still a major health problem in several developing countries. Mumps disease burden in India is still not completely understood. Few published reports indicate more occurrence of the disease in children of the age-group 5-9 years. [4],[5] In the present study it was shown that mumps virus exhibited a positive laboratory result is defined as either: IgM positive or virus detection by RT-PCR. Suspected mumps cases were confirmed by systematic laboratory testing which included IgM test, RT-PCR and sequencing analysis.

A positive IgM test result indicates current infection or reinfection. The detection of mumps virus by RT-PCR method confirms the outbreak due to mumps virus and sequencing analysis further revealed circulation of 'C' genotype as reported earlier in South India.

 ~ Acknowledgement Top

We are thankful to Dr D. T. Mourya, director NIV for providing constant support and valuable suggestions during progression of this study.

 ~ References Top

Hatchette TF, Mahony JB, Chong S, LeBlanc JJ. Difficulty with mumps diagnosis: What is the contribution of mumps mimickers? J Clin Virol 2009;46:381-3.  Back to cited text no. 1
Jin L, Rima B, Brown D, Orvell C, Tecle T, Afzal M, et al. Featherstone D. Proposal for genetic characterization of wild-type mumps strains: Preliminary standardization of the nomenclature. Arch Virol 2005;150:1903-9.  Back to cited text no. 2
Echevarria JE, Castellanos A, Sanz JC, Perez C, Palacios G, Martinez de, et al. Circulation of mumps virus genotypes in Spain from 1996 to 2007. J Clin Microbiol 2010;48:1245-54.  Back to cited text no. 3
Geeta MG, Kumar PK. Mumps-need for urgent action. Indian Pediatr 2004;41:1181-2.  Back to cited text no. 4
Ghatage ST, Kakade GM. An outbreak of mumps meningoencephalitis in Sangli district. Indian Pediatr 2007;44:235.  Back to cited text no. 5
Guidelines for the prevention and control of mumps outbreaks in Canada. Available from: http://www.phac- rmtc/10pdf/36s1-eng [Last accessed on 2014 May 20].  Back to cited text no. 6
Dayan GH, Quinlisk MP, Parker AA, Barskey AE, Harris ML, Schwartz JM, et al. Recent resurgence of mumps in the United States. N Engl J Med 2008;358:1580-9.  Back to cited text no. 7
Inou Y, Nakayama T, Yoshida N, Uejima H, Yuri K, Kamada M, et al. Molecular epidemiology of mumps virus in Japan and proposal of two new genotypes. J Med Virol 2004;73:97-104.  Back to cited text no. 8
Johansson B, Tecle T, Orvell C. Proposed criteria for classification of new genotypes of mumps virus. Scand J Infect Dis 2002;34:355-7.  Back to cited text no. 9
Palacios G, Jabado O, Cisterna D, de Ory F, Renwick N, Echevarría JE, et al. Molecular identification of mumps virus genotypes from clinical samples: Standardized method of analysis. J Clin Microbiol 2005;43:1869-78.  Back to cited text no. 10
Vaidya SR, Chowdhury DT, Kumbhar NS, Tomar R, Kamble MB, Kazi MI. Circulation of two mumps virus genotypes in an unimmunized population in India. J Med Virol 2013;85:1426-32.  Back to cited text no. 11
Jeevan M, Sambantham S, Thangam M. Characterization of mumps virus genotype C among patients with mumps in India. Indian J Med Microbiol 2013;31:290-2.  Back to cited text no. 12
[PUBMED]  Medknow Journal  
John TJ. An outbreak of mumps in Thiruvanthapuram district. Indian Pediatr 2004;41:298-300.  Back to cited text no. 13
Vandana KE, Arunkumar G, Bairy I. Role of laboratory in rapid diagnosis of atypical mumps. Braz J Infect Dis 2010;14:201-2.  Back to cited text no. 14
Ruijs WL, Hautvast JL, Akkermans RP, Hulscher ME, Velden KV. Role of schools in the spread of mumps among unvaccinated children: A retrospective cohort study. BMC Infect Dis 2011;11:227.  Back to cited text no. 15
Peltola H, Kulkarni PS, Kapre SV, Paunio M, Jadhav SS, Dhere RM. Mumps outbreaks in Canada and the United States: Time for new thinking on mumps vaccines. Clin Infect Dis 2007;45:459-66.  Back to cited text no. 16
Muhlemann K. The molecular epidemiology of mumps virus. Infect Genet Evol 2004;4:215-9.  Back to cited text no. 17
Centers for Disease Control and Prevention. Atlanta, GA: US Department of Health and Human Services, CDC; Mumps. Materials and methods for specimen collection, storage, and shipment. 2010. Available from: [Last accessed on 2014 May 20].  Back to cited text no. 18
Royuela E, Castellanos A, Sanchez-Herrero C, Sanz JC, Ory FD, Echevarria JE. Mumps virus diagnosis and genotyping using a novel single RT-PCR. J Clin Virol 2011;52:359-62.  Back to cited text no. 19
Tamura K, Peterson D, Peterson N, Stecher G, Nei M, Kumar S. MEGA5: Molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance and maximum parsimony method. Mol Biol Evol 2011;28:2731-9.  Back to cited text no. 20


  [Figure 1], [Figure 2], [Figure 3], [Figure 4]

  [Table 1]


Print this article  Email this article


2004 - Indian Journal of Medical Microbiology
Published by Wolters Kluwer - Medknow

Online since April 2001, new site since 1st August '04